AustralieFrV1, Main, Exploration, bibRecord, 007049

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure

Identifieur interne : 007049 ( Main/Exploration ); précédent : 007048; suivant : 007050

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure

Auteurs : Giuseppe Ambrosio [Italie] ; Marcus D. Flather [Royaume-Uni] ; Michael Böhm [Allemagne] ; Alain Cohen-Solal [France] ; Adriano Murrone [Italie] ; Flavio Mascagni [Italie] ; Giulio Spinucci [Italie] ; Maria Giovanna Conti [Italie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Luigi Tavazzi [Italie] ; Andrew J S. Coats [Australie]

Source :

Heart [ 1355-6037 ] ; 2011-02-01.

RBID : ISTEX:DC1067A2454AAC099231E35AFC607FE3717BD383

English descriptors

Abstract

Objectives This subanalysis of the Study of the Effects of Nebivolol Intervention on Outcomes and Hospitalisation in Seniors with Heart Failure (SENIORS) investigates whether treatment with nebivolol, a β-blocker with nitric oxide-releasing properties, can provide additional benefits besides its effects on heart failure (HF), by reducing cardiac ischaemic events in patients with HF of ischaemic aetiology. Design A double-blind, randomised, placebo-controlled, multicentre trial of nebivolol in 2128 elderly patients. Patients and interventions For this analysis, data were extracted for 2128 elderly (≥70 years) HF patients in whom coronary artery disease (CAD) was the underlying aetiology (68.2%; 717 placebo-treated patients and 735 assigned to nebivolol). Main outcome measures The main endpoint was the composite of cardiac ischaemic events at 2 year follow-up: death/hospitalisation for myocardial infarction, unstable angina or sudden death, as originally identified in the case report form. Results At follow-up, nebivolol treatment was associated with a one-third reduction in the risk of ischaemic events, the composite endpoint occurring in 15.9% of placebo and 10.7% of nebivolol-treated patients (HR 0.68; 95% CI 0.51 to 0.90; p=0.008). This effect was independent of age, gender and ejection fraction. No difference in this composite endpoint was observed in the subgroup of patients of non-ischaemic aetiology. Conclusions Nebivolol was effective in reducing cardiac ischaemic events in patients with HF of ischaemic aetiology. The prevention of ischaemic events can be an additional beneficial effect of β-blockade in HF patients with underlying CAD.

Url:

https://api.istex.fr/document/DC1067A2454AAC099231E35AFC607FE3717BD383/fulltext/pdf

DOI: 10.1136/hrt.2010.207365

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 002905
to stream Istex, to step Curation: 002905
to stream Istex, to step Checkpoint: 000947
to stream Main, to step Merge: 007582
to stream Main, to step Curation: 007049

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure</title>
<author><name sortKey="Ambrosio, Giuseppe" sort="Ambrosio, Giuseppe" uniqKey="Ambrosio G" first="Giuseppe" last="Ambrosio">Giuseppe Ambrosio</name>
</author>
<author><name sortKey="Flather, Marcus D" sort="Flather, Marcus D" uniqKey="Flather M" first="Marcus D" last="Flather">Marcus D. Flather</name>
</author>
<author><name sortKey="Bohm, Michael" sort="Bohm, Michael" uniqKey="Bohm M" first="Michael" last="Böhm">Michael Böhm</name>
</author>
<author><name sortKey="Cohen Solal, Alain" sort="Cohen Solal, Alain" uniqKey="Cohen Solal A" first="Alain" last="Cohen-Solal">Alain Cohen-Solal</name>
</author>
<author><name sortKey="Murrone, Adriano" sort="Murrone, Adriano" uniqKey="Murrone A" first="Adriano" last="Murrone">Adriano Murrone</name>
</author>
<author><name sortKey="Mascagni, Flavio" sort="Mascagni, Flavio" uniqKey="Mascagni F" first="Flavio" last="Mascagni">Flavio Mascagni</name>
</author>
<author><name sortKey="Spinucci, Giulio" sort="Spinucci, Giulio" uniqKey="Spinucci G" first="Giulio" last="Spinucci">Giulio Spinucci</name>
</author>
<author><name sortKey="Conti, Maria Giovanna" sort="Conti, Maria Giovanna" uniqKey="Conti M" first="Maria Giovanna" last="Conti">Maria Giovanna Conti</name>
</author>
<author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name>
</author>
<author><name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</author>
<author><name sortKey="Coats, Andrew J S" sort="Coats, Andrew J S" uniqKey="Coats A" first="Andrew J S" last="Coats">Andrew J S. Coats</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DC1067A2454AAC099231E35AFC607FE3717BD383</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1136/hrt.2010.207365</idno>
<idno type="url">https://api.istex.fr/document/DC1067A2454AAC099231E35AFC607FE3717BD383/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002905</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002905</idno>
<idno type="wicri:Area/Istex/Curation">002905</idno>
<idno type="wicri:Area/Istex/Checkpoint">000947</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000947</idno>
<idno type="wicri:doubleKey">1355-6037:2010:Ambrosio G:blockade:with:nebivolol</idno>
<idno type="wicri:Area/Main/Merge">007582</idno>
<idno type="wicri:Area/Main/Curation">007049</idno>
<idno type="wicri:Area/Main/Exploration">007049</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure</title>
<author><name sortKey="Ambrosio, Giuseppe" sort="Ambrosio, Giuseppe" uniqKey="Ambrosio G" first="Giuseppe" last="Ambrosio">Giuseppe Ambrosio</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Cardiology, University of Perugia School of Medicine, Perugia</wicri:regionArea>
<wicri:noRegion>Perugia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Italie</country>
</affiliation>
</author>
<author><name sortKey="Flather, Marcus D" sort="Flather, Marcus D" uniqKey="Flather M" first="Marcus D" last="Flather">Marcus D. Flather</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Clinical Trials and Investigation Unit, Royal Brompton and Harefield NHS Trust, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bohm, Michael" sort="Bohm, Michael" uniqKey="Bohm M" first="Michael" last="Böhm">Michael Böhm</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Klinik für Innere Medizin III, Universität des Saarlandes, Homburg/Saar</wicri:regionArea>
<wicri:noRegion>Homburg/Saar</wicri:noRegion>
<wicri:noRegion>Homburg/Saar</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cohen Solal, Alain" sort="Cohen Solal, Alain" uniqKey="Cohen Solal A" first="Alain" last="Cohen-Solal">Alain Cohen-Solal</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U942; Faculté Paris 7 Paris Diderot; Hopital Lariboisiere, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Murrone, Adriano" sort="Murrone, Adriano" uniqKey="Murrone A" first="Adriano" last="Murrone">Adriano Murrone</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Cardiology, University of Perugia School of Medicine, Perugia</wicri:regionArea>
<wicri:noRegion>Perugia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mascagni, Flavio" sort="Mascagni, Flavio" uniqKey="Mascagni F" first="Flavio" last="Mascagni">Flavio Mascagni</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Data Management & Biometry Unit, CAST and TRIAL, Pozzo della Chiana</wicri:regionArea>
<wicri:noRegion>Pozzo della Chiana</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spinucci, Giulio" sort="Spinucci, Giulio" uniqKey="Spinucci G" first="Giulio" last="Spinucci">Giulio Spinucci</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Cardiology, University of Perugia School of Medicine, Perugia</wicri:regionArea>
<wicri:noRegion>Perugia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Conti, Maria Giovanna" sort="Conti, Maria Giovanna" uniqKey="Conti M" first="Maria Giovanna" last="Conti">Maria Giovanna Conti</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Cardiology, University of Perugia School of Medicine, Perugia</wicri:regionArea>
<wicri:noRegion>Perugia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen</wicri:regionArea>
<placeName><settlement type="city">Groningue</settlement>
<region nuts="2" type="province">Groningue (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Cardiology, IRCCS Policlinico San Matteo, Pavia</wicri:regionArea>
<wicri:noRegion>Pavia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coats, Andrew J S" sort="Coats, Andrew J S" uniqKey="Coats A" first="Andrew J S" last="Coats">Andrew J S. Coats</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Faculty of Medicine, University of Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Heart</title>
<title level="j" type="abbrev">Heart</title>
<idno type="ISSN">1355-6037</idno>
<idno type="eISSN">1468-201X</idno>
<imprint><publisher>BMJ Publishing Group Ltd and British Cardiovascular Society</publisher>
<date type="published" when="2011-02-01">2011-02-01</date>
<biblScope unit="volume">97</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="209">209</biblScope>
</imprint>
<idno type="ISSN">1355-6037</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1355-6037</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Additional analyses</term>
<term>Aetiology</term>
<term>American college</term>
<term>Angina</term>
<term>Annual rate</term>
<term>Australiaenew zealand heart</term>
<term>Baseline characteristics</term>
<term>Cardiac</term>
<term>Cardiac ischaemic events</term>
<term>Cardiogenic shock</term>
<term>Cardiol</term>
<term>Cardiology</term>
<term>Cardiovascular</term>
<term>Carvedilol</term>
<term>Case record form</term>
<term>Chronic heart failure</term>
<term>Chronic ischaemic heart disease</term>
<term>Clinical event review committee</term>
<term>Composite endpoint</term>
<term>Composite ischaemic events</term>
<term>Continuous variables</term>
<term>Coronary artery disease</term>
<term>Ejection fraction</term>
<term>Elderly patients</term>
<term>Endpoint</term>
<term>Fatal arrhythmias</term>
<term>Gender</term>
<term>Gure</term>
<term>Heart failure</term>
<term>Hospital admission</term>
<term>Infarction</term>
<term>Interaction test</term>
<term>Ischaemic</term>
<term>Ischaemic aetiology</term>
<term>Ischaemic events</term>
<term>Ischaemic heart disease</term>
<term>Kaplanemeier plot</term>
<term>Metoprolol</term>
<term>Multicentre trial</term>
<term>Myocardial infarction</term>
<term>Nebivolol</term>
<term>Nebivolol group</term>
<term>Nebivolol intervention</term>
<term>Nebivolol treatment</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Original seniors trial</term>
<term>Other causes</term>
<term>Perugia school</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Practice guidelines</term>
<term>Present study</term>
<term>Previous studies</term>
<term>Previous trials</term>
<term>Primary endpoint</term>
<term>Primary outcome</term>
<term>Randomised</term>
<term>Randomised trial</term>
<term>Randomised trials</term>
<term>Randomized trials</term>
<term>Secondary endpoints</term>
<term>Seniors database</term>
<term>Seniors trial</term>
<term>Seniorsecoronary artery disease</term>
<term>Speaker fees</term>
<term>Standard therapy</term>
<term>Statistical analysis</term>
<term>Subgroup</term>
<term>Subgroup analysis</term>
<term>Sudden death</term>
<term>Unexpected death</term>
<term>Unstable angina</term>
<term>Ventricular ejection fraction</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Additional analyses</term>
<term>Aetiology</term>
<term>American college</term>
<term>Angina</term>
<term>Annual rate</term>
<term>Australiaenew zealand heart</term>
<term>Baseline characteristics</term>
<term>Cardiac</term>
<term>Cardiac ischaemic events</term>
<term>Cardiogenic shock</term>
<term>Cardiol</term>
<term>Cardiology</term>
<term>Cardiovascular</term>
<term>Carvedilol</term>
<term>Case record form</term>
<term>Chronic heart failure</term>
<term>Chronic ischaemic heart disease</term>
<term>Clinical event review committee</term>
<term>Composite endpoint</term>
<term>Composite ischaemic events</term>
<term>Continuous variables</term>
<term>Coronary artery disease</term>
<term>Ejection fraction</term>
<term>Elderly patients</term>
<term>Endpoint</term>
<term>Fatal arrhythmias</term>
<term>Gender</term>
<term>Gure</term>
<term>Heart failure</term>
<term>Hospital admission</term>
<term>Infarction</term>
<term>Interaction test</term>
<term>Ischaemic</term>
<term>Ischaemic aetiology</term>
<term>Ischaemic events</term>
<term>Ischaemic heart disease</term>
<term>Kaplanemeier plot</term>
<term>Metoprolol</term>
<term>Multicentre trial</term>
<term>Myocardial infarction</term>
<term>Nebivolol</term>
<term>Nebivolol group</term>
<term>Nebivolol intervention</term>
<term>Nebivolol treatment</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Original seniors trial</term>
<term>Other causes</term>
<term>Perugia school</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Practice guidelines</term>
<term>Present study</term>
<term>Previous studies</term>
<term>Previous trials</term>
<term>Primary endpoint</term>
<term>Primary outcome</term>
<term>Randomised</term>
<term>Randomised trial</term>
<term>Randomised trials</term>
<term>Randomized trials</term>
<term>Secondary endpoints</term>
<term>Seniors database</term>
<term>Seniors trial</term>
<term>Seniorsecoronary artery disease</term>
<term>Speaker fees</term>
<term>Standard therapy</term>
<term>Statistical analysis</term>
<term>Subgroup</term>
<term>Subgroup analysis</term>
<term>Sudden death</term>
<term>Unexpected death</term>
<term>Unstable angina</term>
<term>Ventricular ejection fraction</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">Objectives This subanalysis of the Study of the Effects of Nebivolol Intervention on Outcomes and Hospitalisation in Seniors with Heart Failure (SENIORS) investigates whether treatment with nebivolol, a β-blocker with nitric oxide-releasing properties, can provide additional benefits besides its effects on heart failure (HF), by reducing cardiac ischaemic events in patients with HF of ischaemic aetiology. Design A double-blind, randomised, placebo-controlled, multicentre trial of nebivolol in 2128 elderly patients. Patients and interventions For this analysis, data were extracted for 2128 elderly (≥70 years) HF patients in whom coronary artery disease (CAD) was the underlying aetiology (68.2%; 717 placebo-treated patients and 735 assigned to nebivolol). Main outcome measures The main endpoint was the composite of cardiac ischaemic events at 2 year follow-up: death/hospitalisation for myocardial infarction, unstable angina or sudden death, as originally identified in the case report form. Results At follow-up, nebivolol treatment was associated with a one-third reduction in the risk of ischaemic events, the composite endpoint occurring in 15.9% of placebo and 10.7% of nebivolol-treated patients (HR 0.68; 95% CI 0.51 to 0.90; p=0.008). This effect was independent of age, gender and ejection fraction. No difference in this composite endpoint was observed in the subgroup of patients of non-ischaemic aetiology. Conclusions Nebivolol was effective in reducing cardiac ischaemic events in patients with HF of ischaemic aetiology. The prevention of ischaemic events can be an additional beneficial effect of β-blockade in HF patients with underlying CAD.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
<li>Groningue (province)</li>
<li>Nouvelle-Galles du Sud</li>
<li>Île-de-France</li>
</region>
<settlement><li>Groningue</li>
<li>Londres</li>
<li>Paris</li>
<li>Sydney</li>
</settlement>
<orgName><li>Université de Sydney</li>
</orgName>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Ambrosio, Giuseppe" sort="Ambrosio, Giuseppe" uniqKey="Ambrosio G" first="Giuseppe" last="Ambrosio">Giuseppe Ambrosio</name>
</noRegion>
<name sortKey="Ambrosio, Giuseppe" sort="Ambrosio, Giuseppe" uniqKey="Ambrosio G" first="Giuseppe" last="Ambrosio">Giuseppe Ambrosio</name>
<name sortKey="Conti, Maria Giovanna" sort="Conti, Maria Giovanna" uniqKey="Conti M" first="Maria Giovanna" last="Conti">Maria Giovanna Conti</name>
<name sortKey="Mascagni, Flavio" sort="Mascagni, Flavio" uniqKey="Mascagni F" first="Flavio" last="Mascagni">Flavio Mascagni</name>
<name sortKey="Murrone, Adriano" sort="Murrone, Adriano" uniqKey="Murrone A" first="Adriano" last="Murrone">Adriano Murrone</name>
<name sortKey="Spinucci, Giulio" sort="Spinucci, Giulio" uniqKey="Spinucci G" first="Giulio" last="Spinucci">Giulio Spinucci</name>
<name sortKey="Tavazzi, Luigi" sort="Tavazzi, Luigi" uniqKey="Tavazzi L" first="Luigi" last="Tavazzi">Luigi Tavazzi</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Flather, Marcus D" sort="Flather, Marcus D" uniqKey="Flather M" first="Marcus D" last="Flather">Marcus D. Flather</name>
</region>
</country>
<country name="Allemagne"><noRegion><name sortKey="Bohm, Michael" sort="Bohm, Michael" uniqKey="Bohm M" first="Michael" last="Böhm">Michael Böhm</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Cohen Solal, Alain" sort="Cohen Solal, Alain" uniqKey="Cohen Solal A" first="Alain" last="Cohen-Solal">Alain Cohen-Solal</name>
</region>
</country>
<country name="Pays-Bas"><region name="Groningue (province)"><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name>
</region>
</country>
<country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Coats, Andrew J S" sort="Coats, Andrew J S" uniqKey="Coats A" first="Andrew J S" last="Coats">Andrew J S. Coats</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007049 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007049 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:DC1067A2454AAC099231E35AFC607FE3717BD383
   |texte=   β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri